New FDA Firm, C. Humphrey & Associates. P.A. Announces Phenomenal Growth

C. Humphrey & Associates, P.A. announces phenomenal growth, experiencing a record 50% increase in revenue over a six-month period.

(PRWEB) October 23, 2005 -- C. Humphrey & Associates, P.A. announces phenomenal growth, experiencing a record 50% increase in revenue over a six-month period.

In addition, the Firm has experienced growth as well with a new Associate, Lisa Capote, Denise I. Jones, Senior FDA Consultant, Benny Diaz, Senior Import Consultant and Wani Manly, Co-Counsel of Rodriguez, O’Donnell, Ross, Fuerst, P.C. Ms. Humphrey has over a decade of experience with Food & Drug Administration (“FDA”) focusing her legal practice on FDA matters, including domestic and foreign inspections of all FDA-regulated products; food, drug, medical devices (Quality Systems Regulations), radiological health, biologics, cosmetics, Investigational Review Boards (IRBs), clinical investigations and HACCP requirements, import and export processes; criminal, regulatory and administrative actions, risk management, regulation and agency guidance development and issues related to the FDA’s new bioterrorism rules and regulations.

The firm handles a wide variety of cases involving FDA 483s, warning letters, injunctions, prosecutions, detentions, refusal, Customs penalties and import alerts. Our expertise on promotion and advertising, labeling issues, exports and imports, MDR reporting, QSR and GMP requirements, and other regulatory issues provides our clients with confidence and security that their products and processes are compliant in the most cost-effective manner available. We also prepare our clients for meetings with FDA personnel on compliance matters and represent clients before the Agency on enforcement, policy and rulemaking issues, and litigation.

# # #